Nasal Fentanyl And Renal Colic
1 other identifier
interventional
65
1 country
1
Brief Summary
The purpose of this study is to determine whether nasal fentanyl is effective in the treatment of renal colic in adults in emergency department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 15, 2011
CompletedFirst Posted
Study publicly available on registry
April 20, 2011
CompletedApril 20, 2011
September 1, 2009
8 months
April 15, 2011
April 19, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in visual analogue scale pain intensity score
This measure was obtained using a 10-cm with marked numbers visual analog scale (VAS score).
30 and 60 minutes
Secondary Outcomes (2)
Use of rescue therapy at 30 minutes
30 MINUTES
The occurrence of adverse events
60 minutes
Study Arms (2)
NASAL FENTANYL,
ACTIVE COMPARATORKETOROLAC + MORPHINE
ACTIVE COMPARATORInterventions
morphine 5 MG diluted in saline solution 100 ml followed by 2-ml ampoule of ketorolac 30 MG in saline solution 100 ml was infused:
Eligibility Criteria
You may qualify if:
- The patients were adults aged 18 to 65 years, presenting in ED with classical clinical symptoms of renal colic (sudden monolateral flank pain with inguinal irradiation) with a 10-cm visual analog scale (VAS) greater than or equal to 7
You may not qualify if:
- Were analgesia within 6 hours of arrival
- Allergy to opiates and NSAIDs
- Opiates abuse, known or suspected abdominal aortic dissection or aneurism,
- Presence of peritonitis
- Hemodynamic instability
- Pregnancy, breastfeeding, anticoagulant therapy.
- Patients with known renal, pulmonary, cardiac or hepatic failure, as well as those with renal transplantation, were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Valduce Hospitallead
Study Sites (1)
Valduce Hospital
Como, 22100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 15, 2011
First Posted
April 20, 2011
Study Start
January 1, 2009
Primary Completion
September 1, 2009
Study Completion
September 1, 2009
Last Updated
April 20, 2011
Record last verified: 2009-09